Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke

Most patients survive their first non-cardioembolic ischemic stroke (IS), but a significant proportion of them experience a second stroke within the first year. The main directions for the prevention of recurrent IS are antihypertensive and lipid-lowering therapy, control of glucose levels in patien...

Full description

Bibliographic Details
Main Authors: M. Yu. Maksimova, A. S. Airapetova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-06-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/1828